Abstract:The United Nations and the World Health Organization declared 2000 10 as the Bone and Joint Decade. Since then, China has made substantial progress in developing artificial joints and joint replacement surgery. Nowadays, joint replacement is widely accepted as a successful treatment alternative in China for many end-stage joint conditions when non-operative measures have been exhausted, which is a significant advance in orthopaedics. Joint replacement started in the 1970s, when China lagged behind many countries [1]. Lu Shibi, acknowledged as the father of joint replacement surgery, first developed an artificial joint design using titanium along with the clinical application. However, the early applications in this area were unsuccessful because of the inappropriate design and fabrication of prostheses. In the 1980s, successful development of domestic cement and cementless fixation of pearl-surfaced artificial joints [2, 3] resulted in great progress in joint replacement technology, although still fairly new. Many large hospitals became involved in surgery, leading to domestic production of prostheses. Since the 1990s, China has seen a boom in joint surgery: for example, many hospitals either at or above provincial level have set up joint surgery professional groups, branches or centres. With China’s accession to the World Trade Organization in 1995, many international manufacturers of artificial joints came into the Chinese market. The influx of foreign products promoted the growth of joint replacement surgery as well as triggering local production of artificial joints. In some areas, the technology and practice is close to or on a par with advanced international levels. Meanwhile, the Chinese Joint Surgery Association has grown as an organization, with its members all over the country disseminating knowledge and exchanging academic information. In addition, extensive academic exchanges and co-operation with many international institutions have taken place. Joint surgery is now an accepted treatment option for people suffering from surgically remediable joint diseases and is routinely done all over China. The number of surgeries continues to rise annually by 15%. The age range for joint replacement surgery is 15 105 years [4], but the average age of the patients who receive joint replacements tends to be younger. Most joint replacement surgeries are done for OA, while others are for RA, inflammatory arthritides, JRA, femoral neck fractures, bone tumour and developmental dislocation of the hip. Almost all joints can be replaced: not only the large joints such as hip, knee, ankle, shoulder, elbow and wrist, but also small joints like those of a hand or foot. Despite the rapid growth in joint replacement technology in China, several issues persist. First, the proportion of patients who receive joint replacement shows considerable differences between urban and rural areas. While no official statistics regarding the differences are available, the situation is not hard to visualize. A straightforward joint replacement costs around ¥42 500 ($7000 or £4250) [5], which is beyond the reach of many people in the underdeveloped agricultural areas. Besides the imbalanced distribution of economic resources in China (western China is still poorly developed) and the lack of medical insurance and other financial support, many patients, particularly those in western China, do not have access to joint replacement surgery. It is not done in many under-resourced areas. Secondly, we have an insufficient number of surgeons. So doctors who have not been trained professionally implement joint replacement for patients. In rural areas, most hospitals are in short supply of both surgeons and surgical facilities. The demand for joint surgery nationally still far exceeds supply. Many patients, maybe for different reasons, fail to receive appropriate treatment. Thirdly, the average hospital stay is generally 17 days [6], which, compared with many western countries (average of 4 days), is too long. Fourthly, at present the clinical use of artificial joints depends mainly on foreign imports, and most of the domestic products are an exact imitation of the foreign joints. However, physical differences between Chinese and foreigners in terms of height and bone [7] imply that a simple copy is not an ideal match. In China, about 1.2 billion people have OA, with 55% of them being >60 years of age [8], but about 50 000 hip or knee arthroplasties are annually performed in China; this number is increasing every year, while this number is 900 000 for hip and knee replacements performed annually in the USA [9]. Interestingly, >20 million people in the USA have OA. Some of the steps that are needed to improve and evolve joint surgery in China are highlighted. First, some countries have national joint replacement registers that systematically follow up all patients who have undergone a specific replacement procedure [10], but there is no such nationwide joint replacement registration reporting system in China. Artificial joint surgery in China is still ad hoc. Without a national register, complication rates of

Barriers to Reconstructive Hand Surgery for Rheumatoid Arthritis in China: A Multicenter Survey of Patients and Physicians

Factors in Hand Surgery Access for Rheumatoid Arthritis Before vs After the Patient Protection and Affordable Care Act

Status of robot-assisted artificial total joint arthroplasty in China: a cross-sectional survey of joint surgeons

Physician practices in referring rheumatoid hand and thumb carpometacarpal arthritis cases to hand surgeons

Perception of Perioperative Risk for Arthroplasty Patients: A Poll of Chinese Orthopaedic Surgeons

Access to Reconstructive Hand Surgery in the United States—Investigating the Obstacles: A Scoping Review

Disability and Health-Related Quality of Life in Chinese Patients with Rheumatoid Arthritis: A Cross-Sectional Study.

Investigating the Safety and Compliance of Using Csdmards in Rheumatoid Arthritis Treatment Through Face-to-face Interviews: a Cross-Sectional Study in China.

A multicenter study of deformity and disability in rheumatoid arthritis patients in China

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China

Knowledge, attitudes, and practices of dietary management among patients with rheumatoid arthritis in China

Healthcare disparities: patients' perspectives on barriers to joint replacement

The Impact of Rheumatoid Arthritis on Work Capacity in Chinese Patients: a Cross-Sectional Study

Current Occupational Perspective of Total Hip Joint Surgeons in China: A Survey of Members of the Chinese Orthopedic Association.

Assessing Public-Reported Perceptions of Low-Risk Hand Surgery Provided in the Office Versus an Ambulatory Surgery Center: Survey Study

Evaluation of the Factors Affecting Concerns and Expectations of Patients Undergoing Total Knee Arthroplasty in China.

A multicenter study of fracture in patients with rheumatoid arthritis in China

Limitations of Keratoplasty in China: A Survey Analysis

Joint Replacement in China: Progress and Challenges

Online survey of symptoms and care seeking behavior in 7,956 questionnaire respondents with highly suspected knee arthritis in China (Preprint)

Cardiovascular risk management in rheumatoid arthritis: A large gap to close